United States· US:85477-710_6cd37233-b8b5-4018-b1e4-07611306a562

Bionara ULTRA

A medicinal product containing lactobacillus acidophilus la 14; bifidobacterium animalis lactis bl04; lactiplantibacillus plantarum; lacticaseibacillus paracasei lpc-37; lessonia nigrescens; beta vulgaris root fructooligosaccharides, registered in United States by Oncora Pharma, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBionara ULTRAATC—REGISTER NO.US:85477-710_6cd37233…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LACTOBACILLUS ACIDOPHILUS LA 14; BIFIDOBACTERIUM ANIMALIS LACTIS BL04; LACTIPLANTIBACILLUS PLANTARUM; LACTICASEIBACILLUS PARACASEI LPC-37; LESSONIA NIGRESCENS; BETA VULGARIS ROOT FRUCTOOLIGOSACCHARIDES
Manufacturer
Oncora Pharma, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    8547771030
    30 CAPSULE in 1 BOTTLE (85477-710-30)
  • ndc11
    85477-710-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0b86fd70-f32c-43e8-a148-44447deac8b6
GET /v1/drugs/0b86fd70-f32c-43e8-a148-44447deac8b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "410; 410; 410; 410; 25; 10",
  "substance": "LACTOBACILLUS ACIDOPHILUS LA 14; BIFIDOBACTERIUM ANIMALIS LACTIS BL04; LACTIPLANTIBACILLUS PLANTARUM; LACTICASEIBACILLUS PARACASEI LPC-37; LESSONIA NIGRESCENS; BETA VULGARIS ROOT FRUCTOOLIGOSACCHARIDES",
  "productndc": "85477-710",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1; mg/1; mg/1; mg/1; mg/1",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER"
}

See everything about lactobacillus acidophilus la 14; bifidobacterium animalis lactis bl04; lactiplantibacillus plantarum; lacticaseibacillus paracasei lpc-37; lessonia nigrescens; beta vulgaris root fructooligosaccharides.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.